As previously reported, Morgan Stanley analyst Zack Sopcak downgraded HCA Healthcare (HCA) and Tenet (THC), both to Underweight from Equal Weight, contending that the recently announced deals made by Aetna (AET) for CVS Health (CVS) and UnitedHealthcare (UNH) for DaVita Medical Group highlight the ways payers are becoming increasingly vertically integrated and focusing on reducing medical costs. After analyzing CVS Health's overlap with hospitals and hospitals' exposure to CVS and UnitedHealth (UNH) clinics in states with above average Medicare Advantage share, Sopcak found HCA and Tenet to be most exposed, he tells investors. Noting that he sees the valuations of both as full, he raised his price target on HCA to $84 from $79 and increased his target on Tenet to $15 from $14.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
Augmedix (AUGX) announced the general availability of Augmedix Go for emergency departments, marking the launch of the industry's first fully-automated, generative AI powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (HCA), one of the nation's leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits. "The launch of Augmedix Go in the ED represents our unwavering commitment to develop solutions for health systems that improve their workflows. Our agility and flexible architecture, exhibited by our broad product suite and open network platform, help us address the complex and varying needs of clinicians and providers," said Manny Krakaris, CEO of Augmedix. "We have built a sophisticated platform designed to enable clinicians to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background."